Nektar Therapeutics
NKTR
NKTR
136 hedge funds and large institutions have $1.16B invested in Nektar Therapeutics in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 142 → 136 (-6)
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
Holders
136
Holding in Top 10
1
Calls
$4.46M
Puts
$4.61M
Top Buyers
| 1 | +$28.9M | |
| 2 | +$13.5M | |
| 3 | +$10.7M | |
| 4 |
Bank of New York Mellon
New York
|
+$8.65M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$5.82M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$7.94M | |
| 3 | -$6.01M | |
| 4 |
ICM
IronBridge Capital Management
Oakbrook Terrace,
Illinois
|
-$5.92M |
| 5 |
Barclays
London,
United Kingdom
|
-$5.33M |